Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759808 | SCV000889385 | pathogenic | not provided | 2018-03-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001012378 | SCV001172818 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-06-05 | criteria provided, single submitter | clinical testing | The c.1601delT pathogenic mutation, located in coding exon 14 of the MLH1 gene, results from a deletion of one nucleotide at nucleotide position 1601, causing a translational frameshift with a predicted alternate stop codon (p.V534Gfs*57). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |